Amid a global rush to judgment among several regulatory authorities, pharmaceutical companies, chain drugstores and trial lawyers on the potential carcinogenicity of ranitidine, the US Food and Drug Administration remains a conspicuous holdout.
Now the agency is questioning the third-party test results obtained by an online pharmacy, Valisure LLC, that set the recalls in motion. Valisure is an online pharmacy with a laboratory...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?